// App-Quantinova.ai

: Benefits of Laparoscopy for Major Liver Resection in Cirrhotic Patients: Time for Pushing Indications Beyond the Limits? A Propensity Score Matched Analysis

Researchers

Presenter

  • A. Benedetti Cacciaguerra

Principal Investigators

  • J. Lanari

  • F. Cipriani

  • N. Russolillo

  • F. Mocchegiani

  • G. Zimmitti

  • A. Alseidi

  • A. Ruzzenente

  • B. Edwin

  • M. D’Hondt

  • M. Besselink

  • F. Giuliante

  • D. Fuks

  • F. Rotellar

  • S. Lopez-Ben

  • M. Vivarelli

  • A. Ferrero

  • L. Aldrighetti

  • U. Cillo

  • M. Abu Hilal

Medical Centers

  • Poliambulanza Foundation Hospital, Department of Surgery, Brescia, Italy

  • University Hospital Southampton NHS Foundation Trust, Department of Surgery, United Kingdom

  • Hospital Doctor Josep Trueta de Girona, Servei de Cirurgia General i Digestiva, Spain

  • University of Oslo, The Intervention Centre and Department of HPB Surgery, Oslo University Hospital and Institute of Medicine, Norway

  • Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Department of Surgery, Amsterdam, Netherlands

  • Groeninge Hospital, Department of Digestive and Hepatobiliary/Pancreatic Surgery, Kortrijk, Belgium

  • University of Verona, Department of Surgery, Verona, Italy

  • Padova University Hospital, Department of Surgery, Oncology and Gastroenterology, Hepatobiliary Surgery and Liver Transplantation Unit, Padova, Italy

  • Université Paris Descartes, Department of Digestive, Oncologic and Metabolic Surgery, Institut Mutualiste Montsouris, France

  • Clínica Universidad de Navarra, HPB and Liver Transplant Unit, Department of General and Digestive Surgery, Spain

  • Umberto I Mauriziano Hospital, Department of General and Oncological Surgery, Turin, Italy

  • Università Cattolica del Sacro Cuore-IRCCS, Chirurgia Epatobiliare, Italy

  • Virginia Mason Medical Center, Department of Surgery, Seatle, United States

  • Amsterdam UMC, University of Amsterdam, Department of Surgery, Cancer Center Amsterdam, Amsterdam, Netherlands

  • IRCCS San Raffaele Hospital, Hepatobiliary Surgery Division, Milan, Italy

  • Riuniti Hospital, Polytechnic University of Marche, Hepatobiliary and Abdominal Transplantation Surgery, Department of Experimental and Clinical Medicine, Italy

  • University of California San Francisco, Department of Surgery, United States

Locations

  • Italy

  • Spain

  • United Kingdom

  • Norway

  • United States

  • Netherlands

  • Belgium

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • Folate Hydrolase 1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final